munjit, a bit harsh to compare STP with Medivac. Medivac is a start-up, with limited cash resources and like many start up's has a series of prospective revenue generating opportuntities. Stericorp on the other hand generates approx. $0.75m per month in net operating cashflow, with a GP Margin of 39%. At that rate, STP will generate an amount of net operating cash flow equal to Mediva'c total market cap in just under 12 months. Perhaps Medivac should be talking to Stericorp ?
also like FML, QUB, ACR, HSN
personal comments only. DYOR
STP Price at posting:
$1.90 Sentiment: LT Buy Disclosure: Held
